One month after the FDA asked it to remove an opioid from the market, pharmaceutical maker Endo has announced it will pull the drug.
The company said in a statement posted on its website it still believes in the efficacy and safety of Opana ER, or oxymorphone hydrochloride.
The FDA said the request was the first time it had asked that an opioid pain medication be pulled because of “the public health consequences of abuse.”
Opana ER is a powerful painkiller, about twice as powerful as OxyContin, another often abused opioid.
Endo said it had worked for years to “combat misuse and abuse.” The drug was approved in 2006 and was intended to be used to manage moderate to severe pain over a long period with just one pill.
But addicts crushed it to get a massive high all at once
So, the company made the tablets with a coating that made them hard to crush. It also changed the formula in 2012.
The FDA said post-market data suggested that after the company reformulated the medication, people were injecting it more than they were snorting it.